In a comparative analysis of two Klebsiella pneumoniae isolates from a hospital outbreak, isolate A produces a TEM-type ESBL and is inhibited by ceftriaxone + clavulanic acid. Isolate B produces a metallo-β-lactamase (NDM-1) and remains resistant to ceftriaxone + clavulanic acid. Which finding best distinguishes isolate B (carbapenemase-producing) from isolate A (ESBL-producing)?

Explanation

## Discriminating Metallo-β-lactamase from ESBL Producers ### Core Distinction: Carbapenem Hydrolysis **Key Point:** Metallo-β-lactamases (MBLs) are zinc-dependent enzymes that directly hydrolyze carbapenems (meropenem, imipenem, ertapenem), whereas ESBLs cannot. The clavulanic acid inhibition test is negative for MBLs because clavulanic acid does not inhibit zinc-dependent enzymes—it only inhibits Class A and Class C β-lactamases. ### Comparison of Resistance Patterns | Feature | ESBL (e.g., TEM) | Metallo-β-lactamase (e.g., NDM-1) | |---------|-----------------|-----------------------------------| | **Carbapenem susceptibility** | Susceptible | Resistant | | **Meropenem MIC** | ≤1 μg/mL | ≥4 μg/mL | | **Clavulanic acid inhibition** | Positive (inhibited) | Negative (NOT inhibited) | | **Zinc dependence** | No | Yes | | **Class** | A | B | | **Substrate spectrum** | 3rd/4th gen cephalosporins | Carbapenems + cephalosporins | | **Phenotype** | Cephalosporin-resistant, carbapenem-susceptible | Pan-β-lactam resistant | ### Laboratory Confirmation Methods **High-Yield:** The **Hodge test** (carbapenem inactivation test) and **EDTA-based inhibition test** are gold standards for detecting MBLs: - **EDTA inhibition:** EDTA chelates zinc; if MBL is present, EDTA restores carbapenem susceptibility. - **Clavulanic acid inhibition:** Fails with MBLs (negative), succeeds with ESBLs (positive). **Mnemonic:** **MBL = Metal-dependent, Beta-lactamase, Lethal to carbapenems** — remember that zinc (metal) is the cofactor, and carbapenems are the primary target. ### Diagnostic Algorithm ```mermaid flowchart TD A[Gram-negative with β-lactam resistance]:::outcome --> B{Carbapenem resistant?}:::decision B -->|No| C[ESBL or AmpC producer]:::outcome C --> D[Clavulanic acid inhibition test]:::action D -->|Positive| E[ESBL confirmed]:::outcome B -->|Yes| F[Possible carbapenemase]:::outcome F --> G[EDTA inhibition test]:::action G -->|Positive| H[Metallo-β-lactamase<br/>NDM, VIM, IMP, etc.]:::outcome G -->|Negative| I[Non-MBL carbapenemase<br/>KPC, OXA, etc.]:::outcome ``` **Clinical Pearl:** Isolate B with NDM-1 is a **New Delhi metallo-β-lactamase** producer—a global threat associated with high mortality in nosocomial infections. Its resistance to carbapenems AND failure to be inhibited by clavulanic acid are the hallmark findings. [cite:Koneman's Textbook of Diagnostic Microbiology 7e Ch 6; CLSI M100 Standards]